The major side effect of clozapine is agranulocytosis, a dangerous drop in white blood cells that leaves the body unable to fight infections. This risk is the reason clozapine has historically required mandatory blood monitoring, making it unique among antipsychotic medications. While agranulocytosis affects fewer than 1% of patients, it can be fatal if undetected, and it shaped how this otherwise highly effective drug has been prescribed for decades. Clozapine also carries several other serious side effects worth understanding.
Agranulocytosis: The Defining Risk
Agranulocytosis occurs when your neutrophils, the white blood cells responsible for fighting bacterial infections, drop to dangerously low levels. With clozapine, this means a neutrophil count below 500 cells per microliter of blood, compared to a normal range of roughly 2,500 to 7,000. At that level, even a mild infection can become life-threatening because your immune system essentially has no front line of defense.
Early data from Europe in the 1970s suggested that up to 2% of patients taking clozapine developed this condition. After the drug was introduced in the United States with a monitoring system in place, a study of over 11,500 patients found the cumulative incidence was 0.8% at 12 months. More recent and larger reviews place the risk at approximately 0.7%. The risk is highest during the first 18 weeks of treatment but never fully disappears. If agranulocytosis develops, clozapine must be stopped immediately.
For years, the FDA required a formal risk management program that made prescribers, pharmacies, and patients register in a national database and submit regular blood draws before each prescription could be filled. In a recent policy change, the FDA removed that formal program but still recommends prescribers continue monitoring neutrophil counts on the schedule described in the prescribing information. Blood draws are more frequent early in treatment and taper off over time.
Weight Gain and Metabolic Syndrome
Clozapine causes more weight gain than virtually any other antipsychotic. Patients gain an average of about 13.6 kg (roughly 30 pounds) over a 10-year period, with much of the gain concentrated in the first year. This isn’t just a cosmetic concern. In studies, 30.5% of patients on clozapine eventually developed type 2 diabetes.
The metabolic picture extends well beyond weight. In one observational study of clozapine-treated outpatients, 80% were overweight and 58% met criteria for metabolic syndrome, a cluster of conditions including high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol levels. A separate chart review at community mental health clinics found 45% of clozapine users met the same criteria. These metabolic changes increase the long-term risk of heart disease and stroke, which is why regular monitoring of blood sugar, cholesterol, and weight is a standard part of clozapine treatment.
Gastrointestinal Slowing
Clozapine slows gut movement in a way that goes far beyond ordinary constipation. A large pharmacovigilance study covering over 43,000 patients found that 37 out of every 10,000 clozapine users experienced serious gastrointestinal complications, including bowel obstruction and paralyzed intestines. At least 29 patients in that study died, putting the fatality rate at 7 per 10,000 users and the case fatality rate at 18%. This makes serious gut complications one of the more lethal side effects of clozapine, yet they receive far less attention than agranulocytosis. The study authors noted their figures likely underestimate the true prevalence.
What makes this risk especially important is that it’s preventable with early attention. Constipation that worsens over time, bloating, or abdominal pain should be taken seriously in anyone on clozapine rather than dismissed as a minor nuisance.
Heart Inflammation in the First Six Weeks
Clozapine can cause myocarditis, an inflammation of the heart muscle, typically within the first six weeks of starting treatment. In one electronic health register analysis, the time from starting clozapine to a myocarditis diagnosis ranged from 2 to 42 days, with an average of about 17 days. Symptoms can include chest pain, rapid heartbeat, fatigue, and shortness of breath. Because this window is narrow and predictable, monitoring during the initial weeks of treatment is especially important. Most prescribers check for signs of cardiac inflammation through blood tests and clinical observation during this critical period.
Excessive Salivation
One of the most common and bothersome side effects is hypersalivation, particularly at night. In one study, 92% of patients on clozapine experienced it. Nighttime drooling affected 85% of participants, while 48% also had excess saliva during the day. Despite how widespread this problem is, over 80% of affected patients in that study were receiving no treatment for it at all. Waking up with a soaked pillow or choking on saliva during sleep is not dangerous in most cases, but it significantly affects quality of life and is one of the top reasons patients dislike taking the medication.
Seizures at Higher Doses
Clozapine lowers the seizure threshold in a dose-dependent way. At low doses (under 300 mg per day), the seizure risk is between 0.6% and 2%. At moderate doses (300 to 600 mg per day), that rises to roughly 2.7% to 4%. At high doses (600 mg per day or more), the risk jumps to between 5% and 14%. This is one of the highest seizure rates among antipsychotic medications, and it means that any dose increase needs to be weighed against this growing risk.
Dizziness and Blood Pressure Drops
About 9% of patients experience clinically significant drops in blood pressure when standing up, a condition called orthostatic hypotension. But in patient surveys, the real-world picture looks worse: 40% of clozapine users reported dizziness on standing, and it was the single most influential side effect on patient dissatisfaction with the drug. The risk is managed by starting at a very low dose and increasing slowly, with blood pressure checks in both sitting and standing positions. Older patients and those taking other medications that lower blood pressure may need an even more gradual increase.
Why Clozapine Is Still Prescribed
Given this list of serious side effects, it’s fair to wonder why anyone takes clozapine at all. The answer is that it remains the only antipsychotic proven effective for treatment-resistant schizophrenia, meaning cases where at least two other antipsychotic medications have failed. For these patients, clozapine can be transformative. Some studies have also found that despite its metabolic and cardiac risks, clozapine users do not have higher cardiovascular death rates than users of other antipsychotics. There is even evidence of reduced all-cause mortality and lower suicide rates among clozapine users, likely because the drug is more effective at controlling the psychiatric illness itself. The side effects are real and require vigilant monitoring, but for the specific population clozapine serves, the benefits often outweigh those risks.